Höglund M, Simonsson B, Smedmyr B, Oberg G, Venge P
Department of Clinical Chemistry, University Hospital of Uppsala, Sweden.
Br J Haematol. 1994 Apr;86(4):709-16. doi: 10.1111/j.1365-2141.1994.tb04819.x.
In order to further evaluate the effects of rGM-CSF on the reconstituting granulopoiesis, plasma and serum levels of myeloperoxidase (MPO) and lactoferrin (LF), as well as serum levels of eosinophil cationic protein (ECP), were monitored daily during a period of 3-4 weeks following ABMT in a group of 22 patients treated with either rGM-CSF (n = 11) or placebo (n = 11). Despite faster increase in the neutrophil counts in the rGM-CSF group, we did not observe any difference either in P-MPO or in P-LF during the period of early engraftment (days 11-19). This finding indicates that the proliferative effect of rGM-CSF on the neutropoiesis may be overestimated when neutrophil counts alone are taken into consideration, and suggests that other mechanisms may have contributed to the increase in the number of circulating neutrophils. The ratio of the serum to plasma level of LF, but not of MPO, was higher in the rGM-CSF group, probably reflecting a specific in vivo neutrophil priming effect. In the rGM-CSF group there was a clear increase of S-ECP during the second and third week post transplant, corresponding to an increase in eosinophil counts, which indicates that rGM-CSF stimulated eosinophil reconstitution without causing excessive activation of the mature eosinophils.
为了进一步评估重组人粒细胞巨噬细胞集落刺激因子(rGM-CSF)对粒细胞生成重建的影响,在22例接受rGM-CSF(n = 11)或安慰剂(n = 11)治疗的患者进行自体骨髓移植(ABMT)后的3 - 4周内,每天监测血浆和血清中的髓过氧化物酶(MPO)和乳铁蛋白(LF)水平以及血清嗜酸性粒细胞阳离子蛋白(ECP)水平。尽管rGM-CSF组中性粒细胞计数上升更快,但在早期植入阶段(第11 - 19天),我们未观察到P-MPO或P-LF有任何差异。这一发现表明,仅考虑中性粒细胞计数时,rGM-CSF对中性粒细胞生成的增殖作用可能被高估,提示可能有其他机制导致循环中性粒细胞数量增加。rGM-CSF组中LF的血清与血浆水平之比高于MPO,这可能反映了体内特定的中性粒细胞激活作用。在rGM-CSF组中,移植后第二和第三周S-ECP明显增加,这与嗜酸性粒细胞计数增加相对应,表明rGM-CSF刺激了嗜酸性粒细胞重建,而不会导致成熟嗜酸性粒细胞过度激活。